Newborn and Infant Nursing Reviews
Volume 8, Issue 1 , Pages e7-e10 , March 2008

Nasal Bone Measurement To Diagnose Down Syndrome

  • Shannon Stevenson, MSN, RNC, NNP

      Affiliations

    • Corresponding Author InformationAddress correspondences to Shannon Stevenson, MSN, RNC, NNP, 11540 Mansfield Drive, Frisco, TX 75035.

References 

  1. Bekker M, Twisk J, Vugt J. Reproducibility of the fetal nasal bone length measurement. J Ultrasound. 2004;23:1613–1618
  2. Simeth-Blindman R, Hosmer W, Feldstein V, et al. Second-trimester ultrasound to detect fetuses with Down syndrome. Jama. 2001;285:1044–1055
  3. Bromley B, Shipp T, Benacerraf B. Genetic sonogram scoring index: accuracy and clinical utility. J Ultrasound Med. 1999;18:523–528
  4. Down L. Observations on an ethnic classification of idiots. In: Clinical Lectures and Reports. Vol. 3:London: London Hospital; 1866;p. 259–262
  5. Cicero S, Rembouskos G, Vandecruys H, et al. Likelihood ration for trisomy 21 in fetuses with absent nasal bone at the 11-14 week scan. Ultrasound Obstet Gynecol. 2004;23:218–223
  6. Gamez F, Ferreiro P, Salmean J. Ultrasound measurement of fetal nasal bone in a low-risk population at 19-22 gestational weeks. Ultrasound Obstet Gynecol. 2004;23:152–153
  7. Orlandi F, Rossi C, Orlandi E, et al. First trimester screening for trisomy-21 using a simplified method to assess the presence or absence of the fetal nasal bone. Am J Obstet Gynecol. 2005;192:1107–1111
  8. Cicero S, Bindra R, Rembouskos G, et al. Integrated Ultrasound and biochemical screening for trisomy 21 using fetal nuchal translucency, absent fetal nasal bone, free beta-hCG and PAPP-A at 11 to 14 weeks. Prenat Diagn. 2003;23:306–310
  9. Cicero S, Dezerega V, Andrade E, et al. Learning curve for sonographic examination of the fetal nasal bone at 11-14 weeks. Ultrasound Obstet Gynecol. 2003;22:135–137
  10. Malone F, Ball R, Nyberg D, et al. First-trimester nasal bone evaluation for aneuploidy in the general population. Obstet Gynecol. 2004;104:1222–1228
  11. Chen M, Lee C, Tang R, et al. First-trimester examination of fetal nasal bone. Prenat Diagn. 2006;26:703–706
  12. Prefumo R, Sairam S, Bhide A, et al. Maternal ethnic origin and fetal nasal bones at 11-14 weeks of gestation. Br J Obstet Gynecol. 2004;111:109–112
  13. Chen M, Lee C, Leung K, et al. Pilot study on the midsecond trimester examination of fetal nasal bone in the Chinese population. Prenat Diagn. 2004;24:87–91
  14. Kanellopoulos V, Katsetos C, Economides D. Examination of fetal nasal bone and repeatability of measurement in early pregnancy. Ultrasound Obstet Gynecol. 2003;22:131–134
  15. Prefumo F, Sairam S, Bhide A, Thilaganathan B. First-trimester nuchal translucency, nasal bones, and trisomy 21 in selected and unselected populations. Am J Obstet Gynecol. 2006;194:822–833
  16. Odibo A, Sehdev H, Dunn L, et al. The association between fetal nasal bone hypoplasia and aneuploidy. Obstet Gynecol. 2004;104:1229–1233
  17. Ramos-Corpas D, Santiago J, Montoya F. Ultrasonographic evaluation of fetal nasal bone in a low-risk population at 11–13+6 gestational weeks. Prenat Diagn. 2006;26:112–117
  18. Benoit B, Chaoui R. Three-dimensional Ultrasound with maximal mode rendering: a novel technique for the diagnosis of bilateral or unilateral absence or hypoplasia of nasal bone in second-trimester screening for Down syndrome. Ultrasound Obstet Gynecol. 2005;25:19–24
  19. Goncalves L, Espinoza J, Lee W, et al. Phenotypic characteristics of absent and hypoplastic nasal bones in fetuses with Down syndrome. J Ultrasound Med. 2004;23:1619–1627
  20. Bergann A, Bamberg C, Eder K, et al. Mid-facial anthropometry in second-trimester fetuses with trisomy 21: a three-dimensional Ultrasound study. Prenat Diagn. 2006;26:158–162
  21. Odibo A, Sehdev H, Sproat L, et al. Evaluating the efficiency of using second-trimester nasal bone hypoplasia as a single or a combined marker for fetal aneuploidy. J Ultrasound Med. 2006;25:437–441
  22. Monni G, Zoppi M, Ibba R, et al. Muchal translucency and nasal bone for trisomy 21 screening: single center experience. Croal Med J. 2005;46:786–791
  23. Nicolaides K, Spencer K, Avgidou K, et al. Multicenter study of first-trimester screening for trisomy 21 in 75,821 pregnancies: results and estimation of the potential impact of individual risk-oriented two-stage first-trimester screening. Ultrasound Obstet Gynecol. 2005;25:221–226
  24. Cicero S, Sonek J, McKenna D, et al. Nasal bone hypoplasia in trisomy 21 at 15–22 weeks' gestation. Ultrasound Obstet Gynecol. 2003;21:15–18
  25. Viora E, Errante G, Sciarrone A, et al. Fetal nasal bone and trisomy 21 in the second trimester. Prenat Diagn. 2005;25:511–515
  26. Drugan A. Advanced maternal age and prenatal diagnosis: it's time for individual assessment of genetic risks. Imaj. 2005;7:99–102
  27. Eiben B, Glaubitz R. First-trimester screening: an overview. J Histochem Cytochem. 2005;53:281–283
  28. Nicolaides K. Screening for chromosomal defects. Ultrasound Obstet Gynecol. 2003;21:313–321
  29. Filley R. Obstetrical Ultrasound: the best way to terrify a pregnant woman. J Ultrasound Med. 2000;19:1–5

PII: S1527-3369(07)00187-0

doi: 10.1053/j.nainr.2007.12.007

Newborn and Infant Nursing Reviews
Volume 8, Issue 1 , Pages e7-e10 , March 2008

Article Tools